Uncommon manifestation of poisoning with a mixture of pesticides

Autor: Sigari Aa, Esfahani Nn, Tavakoli N, Hashemzadeh M, Zoofaghari s

The use of pesticides for suicide commitment purposes is a major problem. The present study reports a death due to committing suicide using combination of diazinon, Chlorpyrifos, Trifluralin, Fenpropathrin, Pyriproxyfen, and Cypermethrin. It is diffi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68e2275e3b4b7323591cc6fa9ecc903c
https://doi.org/10.22541/au.162630038.80244246/v1

Effect of enteral probiotics on prognostic scores and C-reactive protein levels in critically ill multiple trauma patients: A randomized, double-blind, placebo-controlled clinical trial.

Autor: Abbasi S; Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: s_abbasi@med.mui.ac.ir., Sigari AA; Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: amirsigari@aol.com., Rostami S; Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: srostami1876@gmail.com., Sedaghat N; Neurosurgery Research Center, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: nahad.sedaghat@gmail.com., Tavakoli R; Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Radiology, Arak University of Medical Sciences, Arak, Iran. Electronic address: RezaT202@res.mui.ac.ir.

Publikováno v: Clinical nutrition ESPEN [Clin Nutr ESPEN] 2023 Jun; Vol. 55, pp. 30-37. Date of Electronic Publication: 2023 Mar 02.

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.

Autor: Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Abhari AP; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Iran., Nouri H; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Iran., Sigari AA; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Piran Daliyeh SM; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Maracy MR; Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran., Salari M; Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Maleki S; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Sedaghat N; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.; Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Iran.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 2041945. Date of Electronic Publication: 2022 Feb 24.

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies.

Autor: Etemadifar M; Department of Neurosurgery, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Sami R; Department of Internal Medicine, Khorshid University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Salari M; Department of Neurology, Shahid Beheshti University, Tehran, Iran., Sedaghat N; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Sigari AA; Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Aghababaei A; School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Najafi M; Department of Neurology, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran., Tehrani DS; Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran.

Publikováno v: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences [J Res Med Sci] 2021 Sep 30; Vol. 26, pp. 85. Date of Electronic Publication: 2021 Sep 30 (Print Publication: 2021).

Rituximab induced cytokine release syndrome in an MS patient: A case report.

Autor: Etemadifar M; Department of Neurosurgery Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran., Salari M; Functional Neurosurgery Research Center Shohada Tajrish Comprehensive Neurosurgical Center of Excellence Shahid Beheshti University of Medical Sciences Tehran Iran., Saeri M; Alzahra Research Institute Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran., Sigari AA; Alzahra Research Institute Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran., Ebrahimi Pelarti S; Alzahra Research Institute Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran.

Publikováno v: Clinical case reports [Clin Case Rep] 2021 Jul 09; Vol. 9 (7), pp. e04407. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021).